174 related articles for article (PubMed ID: 36478349)
1. Characterization of myeloid signature genes for predicting prognosis and immune landscape in Ewing sarcoma.
Zhang Z; Shi Y; Zhu Z; Fu J; Liu D; Liu X; Dang J; Tao H; Fan H
Cancer Sci; 2023 Apr; 114(4):1240-1255. PubMed ID: 36478349
[TBL] [Abstract][Full Text] [Related]
2. Expression of lactate-related signatures correlates with immunosuppressive microenvironment and prognostic prediction in ewing sarcoma.
Zhang Z; Pan J; Cheng D; Shi Y; Wang L; Mi Z; Fu J; Tao H; Fan H
Front Genet; 2022; 13():965126. PubMed ID: 36092937
[No Abstract] [Full Text] [Related]
3. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
[TBL] [Abstract][Full Text] [Related]
4. A Novel Defined Hypoxia-Related Gene Signature for Prognostic Prediction of Patients With Ewing Sarcoma.
Jiang R; Hu J; Zhou H; Wei H; He S; Xiao J
Front Genet; 2022; 13():908113. PubMed ID: 35719404
[TBL] [Abstract][Full Text] [Related]
5. Anoikis patterns exhibit distinct prognostic and immune landscapes in Osteosarcoma.
Zhang Z; Zhu Z; Fu J; Liu X; Mi Z; Tao H; Fan H
Int Immunopharmacol; 2023 Feb; 115():109684. PubMed ID: 36630752
[TBL] [Abstract][Full Text] [Related]
6. An immune-related gene signature for determining Ewing sarcoma prognosis based on machine learning.
Ren EH; Deng YJ; Yuan WH; Wu ZL; Zhang GZ; Xie QQ
J Cancer Res Clin Oncol; 2021 Jan; 147(1):153-165. PubMed ID: 32968877
[TBL] [Abstract][Full Text] [Related]
7. The Landscape of the Tumor Microenvironment in Skin Cutaneous Melanoma Reveals a Prognostic and Immunotherapeutically Relevant Gene Signature.
Zhou S; Sun Y; Chen T; Wang J; He J; Lyu J; Shen Y; Chen X; Yang R
Front Cell Dev Biol; 2021; 9():739594. PubMed ID: 34660598
[TBL] [Abstract][Full Text] [Related]
8. Construction of a novel choline metabolism-related signature to predict prognosis, immune landscape, and chemotherapy response in colon adenocarcinoma.
Liu C; Liu D; Wang F; Liu Y; Xie J; Xie J; Xie Y
Front Immunol; 2022; 13():1038927. PubMed ID: 36451813
[TBL] [Abstract][Full Text] [Related]
9. Identification of molecular subtypes and a novel prognostic model of diffuse large B-cell lymphoma based on a metabolism-associated gene signature.
He J; Chen Z; Xue Q; Sun P; Wang Y; Zhu C; Shi W
J Transl Med; 2022 Apr; 20(1):186. PubMed ID: 35468826
[TBL] [Abstract][Full Text] [Related]
10. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
11. Establishment and validation of an aging-related risk signature associated with prognosis and tumor immune microenvironment in breast cancer.
Wang Z; Liu H; Gong Y; Cheng Y
Eur J Med Res; 2022 Dec; 27(1):317. PubMed ID: 36581948
[TBL] [Abstract][Full Text] [Related]
12. A Nomogram for Predicting Cancer-Specific Survival of Osteosarcoma and Ewing's Sarcoma in Children: A SEER Database Analysis.
Wang J; Zhanghuang C; Tan X; Mi T; Liu J; Jin L; Li M; Zhang Z; He D
Front Public Health; 2022; 10():837506. PubMed ID: 35178367
[TBL] [Abstract][Full Text] [Related]
13. Glycolysis-Metabolism-Related Prognostic Signature for Ewing Sarcoma Patients.
Jia F; Liu L; Weng Q; Zhang H; Zhao X
Mol Biotechnol; 2023 Sep; ():. PubMed ID: 37775679
[TBL] [Abstract][Full Text] [Related]
14. Construction of a novel model based on cell-in-cell-related genes and validation of KRT7 as a biomarker for predicting survival and immune microenvironment in pancreatic cancer.
Song J; Ruze R; Chen Y; Xu R; Yin X; Wang C; Xu Q; Zhao Y
BMC Cancer; 2022 Aug; 22(1):894. PubMed ID: 35974300
[TBL] [Abstract][Full Text] [Related]
15. Identification and validation of redox-immune based prognostic signature for hepatocellular carcinoma.
Tu K; Li J; Mo H; Xian Y; Xu Q; Xiao X
Int J Med Sci; 2021; 18(9):2030-2041. PubMed ID: 33850474
[TBL] [Abstract][Full Text] [Related]
16. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
Front Immunol; 2022; 13():947802. PubMed ID: 36405735
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy-Associated Plasma Protein-A (PAPP-A) in Ewing Sarcoma: Role in Tumor Growth and Immune Evasion.
Heitzeneder S; Sotillo E; Shern JF; Sindiri S; Xu P; Jones R; Pollak M; Noer PR; Lorette J; Fazli L; Alag A; Meltzer P; Lau C; Conover CA; Oxvig C; Sorensen PH; Maris JM; Khan J; Mackall CL
J Natl Cancer Inst; 2019 Sep; 111(9):970-982. PubMed ID: 30698726
[TBL] [Abstract][Full Text] [Related]
18. MiR-708-5p is inversely associated with EWS/FLI1 Ewing sarcoma but does not represent a prognostic predictor.
Roberto GM; Vieira GM; Delsin LEA; Silva MO; Hakime RG; Engel EE; Scrideli CA; Tone LG; Brassesco MS
Cancer Genet; 2019 Jan; 230():21-27. PubMed ID: 30470587
[TBL] [Abstract][Full Text] [Related]
19. Activation of Wnt/β-Catenin in Ewing Sarcoma Cells Antagonizes EWS/ETS Function and Promotes Phenotypic Transition to More Metastatic Cell States.
Pedersen EA; Menon R; Bailey KM; Thomas DG; Van Noord RA; Tran J; Wang H; Qu PP; Hoering A; Fearon ER; Chugh R; Lawlor ER
Cancer Res; 2016 Sep; 76(17):5040-53. PubMed ID: 27364557
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive analysis of a glycolysis and cholesterol synthesis-related genes signature for predicting prognosis and immune landscape in osteosarcoma.
Xu F; Yan J; Peng Z; Liu J; Li Z
Front Immunol; 2022; 13():1096009. PubMed ID: 36618348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]